Showing results (581-590 of 2,543) with videos related to

Sort By:
Pageof 255
International Journal of Technology Assessment in Health Care|December 11, 1987
Data bases for the assessment of medical technologies. Examples from EuropeF Gutzwiller, R Chrzanowski, F Paccaud
International Journal of Technology Assessment in Health Care|October 24, 2002
Health technology assessment for medical devices in Europe. What must be consideredMarkus Siebert, Louis Christian Clauss, Malcolm Carlisle, et al.
International Journal of Technology Assessment in Health Care|July 12, 2001
Analyzing differences in the costs of treatment across centers within economic evaluationsD Coyle, M F Drummond
International Journal of Technology Assessment in Health Care|May 2, 2001
Estimating the Bayesian loss function. A conjoint analysis approachM V Bala, J Mauskopf
International Journal of Technology Assessment in Health Care|May 2, 2001
Bayesian cost-effectiveness analysis. An example using the GUSTO trialD G Fryback, J O Chinnis, J W Ulvila
International Journal of Technology Assessment in Health Care|September 21, 2006
Decision makers' and scientists' opinion about contingent valuation and choice experiments for measuring willingness to pay in health care: results from a survey in GermanyOliver H Günther, Hans-Helmut König
International Journal of Technology Assessment in Health Care|July 17, 1999
Gender differences in the treatment of patients with acute myocardial ischemia and infarction in EnglandR A Raine, T J Crayford, K L Chan, et al.
International Journal of Technology Assessment in Health Care|March 11, 2016
REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPEOlena Mandrik, Saskia Knies, Zoltan Kalo, et al.
International Journal of Technology Assessment in Health Care|April 25, 2017
CARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONSSophie Gerkens, Hans Van Brabandt, Anja Desomer, et al.
International Journal of Technology Assessment in Health Care|June 16, 2020
Disagreement on cancer drug decisions in EuropeLaia Maynou, John Cairns
Pageof 255